ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vincerx Inc

Vincerx Inc (VINC)

0.365
0.016
(4.58%)
At close: November 01 4:00PM
0.3468
-0.0182
( -4.99% )
After Hours: 6:07PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.3468
Bid
0.338
Ask
0.3764
Volume
110,155
0.3336 Day's Range 0.365
0.33 52 Week Range 9.3722
Market Cap
Previous Close
0.349
Open
0.349
Last Trade
1
@
0.3468
Last Trade Time
17:14:57
Financial Volume
$ 39,088
VWAP
0.354847
Average Volume (3m)
525,922
Shares Outstanding
29,671,903
Dividend Yield
-
PE Ratio
-14.04
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-40.16M

About Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.35. Over the last year, Vincerx shares have traded in a share price range of $ 0.33 to $ 9.3722.

Vincerx currently has 29,671,903 shares outstanding. The market capitalization of Vincerx is $10.36 million. Vincerx has a price to earnings ratio (PE ratio) of -14.04.

VINC Latest News

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptxβ„’...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0402-10.38759689920.3870.40980.334042490.36322702CS
4-0.3732-51.83333333330.720.760.3311765000.46554562CS
12-0.2491-41.80231582480.59590.850.335259220.52507217CS
26-0.4732-57.70731707320.820.9350.333472540.5825654CS
52-0.5997-63.35974643420.94659.37220.336029971.94206981CS
156-13.8532-97.557746478914.215.2850.332811862.09767125CS
260-19.7732-98.276341948320.1226.750.332453423.60564736CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUWENewellis Inc
$ 2.23
(63.97%)
3.46M
HRYUHanryu Holdings Inc
$ 0.2661
(24.40%)
6.1M
HOFVHall of Fame Resort and Entertainment Company
$ 1.40
(16.67%)
3.06k
BAOSBaosheng Media Group Holdings Ltd
$ 2.11
(13.39%)
3.49k
CGBSCrown LNG Holdings Ltd
$ 0.295
(10.90%)
1.93M
FRESFresh2 Group Ltd
$ 1.75
(-14.22%)
2.41k
EPRXEupraxia Pharmaceuticals Inc
$ 2.74
(-11.61%)
2.85k
NMHINatures Miracle Holding Inc
$ 0.1003
(-11.24%)
950.2k
NBNioCorp Developments Ltd
$ 1.43
(-10.06%)
49.39k
VEROVenus Concept Inc
$ 0.389
(-9.53%)
2.94k
ELABElevai Labs Inc
$ 0.029
(0.35%)
9.22M
NVDANVIDIA Corporation
$ 139.19
(2.80%)
6.96M
AQMSAqua Metals Inc
$ 0.1399
(1.67%)
6.67M
HRYUHanryu Holdings Inc
$ 0.2661
(24.40%)
6.1M
NUWENewellis Inc
$ 2.23
(63.97%)
3.46M

VINC Discussion

View Posts
tw0122 tw0122 4 weeks ago
VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
πŸ‘οΈ0
Laster Laster 6 months ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
Tomorrow will be $1.50
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
Blood bath. I should have waited one more day.
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
Somebody knows something you don’t
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
I don’t find the price and volume the capital raise is. Am I missing anything here?
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
Check for SEC filings
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
Is the capital raise 80% discounted to yesterday price? Insane
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
Check for a capital raise which means dilution
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
πŸ‘οΈ0
RAlbert RAlbert 7 months ago
Wonder why there is a steep fall in price when the results are not negative.
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
VINC 10Q due 4/3
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
VINC new 52.week hi
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Tom turtles Tom turtles 8 months ago
Very nice surprise...🆙⬆️
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
VINC new 52 week high
πŸ‘οΈ0
glenn1919 glenn1919 8 months ago
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 8 months ago
160k wall getting gobbled up
πŸ‘οΈ0
Awl416 Awl416 8 months ago
Another leg. Damn
πŸ‘οΈ0
Awl416 Awl416 8 months ago
Who’s poking it?
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
VINC under $2
πŸ‘οΈ0
make it happen make it happen 10 months ago
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
πŸ‘οΈ0
alchemytrader alchemytrader 10 months ago
moving...
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
VINC under $2
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock